MoneyWorks4Me

Biocon - Quaterly Results

06 Aug 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 6245.00 millions grew by 16.27 % from Rs. 5371.00 millions.The Total Profit for the quarter ended June 2026 of Rs. 522.00 millions grew from Rs.-83.00 millionsThe company reported a good operating profit of 1256.00 millions compared to 819.00 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 6245.00 5371.00 16.27 6245.00 5371.00 16.27 23464.00 22426.00 4.63
Other Income 648.00 613.00 5.71 648.00 613.00 5.71 3197.00 2423.00 31.94
PBIDT 1256.00 819.00 53.36 1256.00 819.00 53.36 5458.00 4181.00 30.54
Interest 173.00 562.00 -69.22 173.00 562.00 -69.22 1424.00 2369.00 -39.89
PBDT 1083.00 257.00 321.40 1083.00 257.00 321.40 1883.00 7887.00 -76.13
Depreciation 384.00 333.00 15.32 384.00 333.00 15.32 1373.00 1278.00 7.43
PBT 699.00 -76.00 -1019.74 699.00 -76.00 -1019.74 510.00 6609.00 -92.28
TAX 177.00 7.00 2428.57 177.00 7.00 2428.57 138.00 516.00 -73.26
Deferred Tax 10.00 -4.00 -350.00 10.00 -4.00 -350.00 18.00 11.00 63.64
PAT 522.00 -83.00 -728.92 522.00 -83.00 -728.92 372.00 6093.00 -93.89
Equity 8148.00 6685.00 21.88 8148.00 6685.00 21.88 8105.00 6003.00 35.02
PBIDTM(%) 20.11 15.25 31.89 20.11 15.25 31.89 23.26 18.64 24.77

Biocon Share Price

430.00 -7.50 (-1.71%)
07-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1949.00
Dr. Reddys Labs. 1172.00
Cipla 1472.00
Lupin 2360.00
Zydus Lifesciences 1115.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: